The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
INTRODUCTION: The purpose of the present study was to investigate the relationship of expression of hypoxia inducible factor (HIF)-1α-modifying enzymes prolyl hydroxylase (PHD)1, PHD2 and PHD3 to response of tumours and survival in breast cancer patients enrolled in a phase II trial of neoadjuvant a...
প্রধান লেখক: | Fox, S, Generali, D, Berruti, A, Brizzi, M, Campo, L, Bonardi, S, Bersiga, A, Allevi, G, Milani, M, Aguggini, S, Mele, T, Dogliotti, L, Bottini, A, Harris, A |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
2011
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen
অনুযায়ী: Fox, S, অন্যান্য
প্রকাশিত: (2011) -
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
অনুযায়ী: Mele, T, অন্যান্য
প্রকাশিত: (2010) -
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
অনুযায়ী: Mele, T, অন্যান্য
প্রকাশিত: (2010) -
Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer
অনুযায়ী: Generali, D, অন্যান্য
প্রকাশিত: (2007) -
Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer.
অনুযায়ী: Generali, D, অন্যান্য
প্রকাশিত: (2007)